ÂÜÀòÂÒÂ×

Maxwell Skor serves as Vice President in Biotech Equity Research at Morgan Stanley, following a progression from Associate in the same field. Prior experience includes research roles at Editas Medicine focusing on Ophthalmology, Agios Pharmaceuticals concentrating on Rare Diseases, and The University of Chicago specializing in Hematology/Oncology.